The transcription factor c-Maf exerts immunomodulatory effects by binding to the promoter regions of anti-inflammatory genes, which thus suppresses the activity of Th17 cells and attenuates CNS inflammation and damages in MS (96). Here, MAF is linked to myeloid sarcoma.